BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18807485)

  • 1. [Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
    Inglot M; Szymczak A; Gasiorowski J
    Przegl Epidemiol; 2008; 62(2):383-91. PubMed ID: 18807485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
    Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
    Mauss S
    J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.
    Denholm JT; Wright EJ; Street A; Sasadeusz JJ
    Haemophilia; 2009 Mar; 15(2):538-43. PubMed ID: 19187189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic hepatitis C in HIV-infected patients. Unfavorable interaction of HIV and HCV infection].
    Mauss S
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():60-2. PubMed ID: 10863316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.
    Romero M; Pérez-Olmeda M; García-Samaniego J; Soriano V
    Drug Saf; 2004; 27(1):7-24. PubMed ID: 14720084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of chronic hepatitis C in the setting of HIV co-infection.
    Michielsen P; Bottieau E
    Acta Gastroenterol Belg; 2005; 68(1):86-91. PubMed ID: 15832592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and hepatitis C co-infection.
    Jones R; Dunning J; Nelson M
    Int J Clin Pract; 2005 Sep; 59(9):1082-7. PubMed ID: 16115185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area.
    Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A
    Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-related liver disease: infections versus drugs.
    Sidiq H; Ankoma-Sey V
    Gastroenterol Clin North Am; 2006 Jun; 35(2):487-505. PubMed ID: 16880076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A golden opportunity: the treatment of hepatitis C in HIV-infected inmates.
    McGovern B
    J Addict Dis; 2008; 27(2):69-73. PubMed ID: 18681193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the evidence from clinical trials in chronic hepatitis C.
    Brown RS
    J Viral Hepat; 2006 May; 13 Suppl 1():15-25. PubMed ID: 16630043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
    Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
    Hansen N; Obel N; Christensen PB; Krarup H; Laursen AL; Clausen MR; Lunding S; Møller A; Schlichting P; Kromann-Andersen H; Bukh J; Weis N;
    J Viral Hepat; 2009 Sep; 16(9):659-65. PubMed ID: 19486467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Almost 6,000 double-infected patients in Germany. Hepatitis C burden in HIV patients].
    MMW Fortschr Med; 2000; 142(3 Suppl):19. PubMed ID: 10893954
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing chronic hepatitis C in relapsers and non-responders.
    Montalbano M; Kemmer N; Neff GW
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):31-47. PubMed ID: 18299666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference.
    Salmon D; Robain M; Rockstroh JK; Benhamou Y
    J Hepatol; 2006; 44(1 Suppl):S2-5. PubMed ID: 16360970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.